Evotec Announces Chief Scientific Officer Transition
Dr. Cord Dohrmann to step down as of September 30, 2026Search ongoing for a successorHAMBURG, Germany, Sept. 29, 2026 /PRNewswire/...
Read moreDetails
Press Releases – Lifestyle
Nel ASA: Receives purchase order from Collins Aerospace for US Navy stacks
OSLO, Norway, Sept. 29, 2026 /PRNewswire/ -- Nel Hydrogen US, a subsidiary of Nel ASA (Nel) (OSE: NEL) has received a new...
Read moreDetails
Implantica’s RefluxStop® U.S. market launch kicked off at the 2026 American Foregut Society Meeting, receiving an outstanding reception
VADUZ, Liechtenstein, Sept. 29, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology...
Read moreDetailsValmet confirms the key dates for its second dividend instalment: EUR 0.67 per share to be paid out on October 7, 2026
Valmet Oyj's stock exchange release on September 29, 2026 at 09:00. a.m. EESTESPOO, Finland, Sept. 29, 2026 /PRNewswire/ -- Valmet's Board...
Read moreDetailsSegway Powersports Brings Latin American and Canadian Media and Creators from Factory Floor to Real-World Terrain
CHANGZHOU, China, Sept. 29, 2026 /PRNewswire/ -- Segway Powersports hosted 14 media representatives and creators from Canada, Chile, Peru, Panama, Brazil...
Read moreDetails
iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa
- Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China....
Read moreDetailsYR Fitness Plans to Expand One-Stop Gym Solutions With Design and Fit-Out Services
SHANGHAI, Sept. 29, 2026 /PRNewswire/ -- YR Fitness has announced plans to expand its existing one-stop commercial gym solution with...
Read moreDetailsHengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
HRS-1596 is a phase I-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total potential deal value is up to 2.6 billion US dollars, including 300 million dollars upfront, as well as potential sales...
Read moreDetailsZoomlion Signs US$300 Million Credit Insurance Policy and Initial US$50 Million Non-Recourse Factoring Agreement
SHANGHAI, Sept. 29, 2026 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") signed a US$300 million portfolio credit...
Read moreDetailsSweden Opens Travel Agency for Introverts
STOCKHOLM, Sept. 29, 2026 New research reveals a growing demand for quieter travel: 67% of travellers prefer destinations where social interaction...
Read moreDetails